• Welcome to Renmin Hospital of Wuhan University
  • 网站首页 中文版 English Francaise
  • 付振明 肿瘤
    肿瘤Ⅱ科主任,肿瘤中心副主任,教授,主任医师,博士生导师,美国NIH研究员
    A+ A-
    导师介绍

    姓名 付振明
    出生年月 1972年8月
    单位 武汉大学人民医院肿瘤科
    所属学科 临床医学-放射肿瘤学
    职务、职称及头衔 肿瘤II科主任,肿瘤中心副主任,教授,主任医师,博士生导师,美国NIH研究员
    E-mail davidfuzming@whu.edu.cn
    联系方式 027-88041911-88638
    研究方向 1.肿瘤的精准放化疗研究
    2.肿瘤转化流行病学研究
    个人简介
    1.一直从事肿瘤的精准放化疗临床及研究,为国内最早的一批从事调强放疗的专家。通过美国执业医师考试。参与制定多种肿瘤的国家及国际指南的制订,提出的胃癌术后放疗方法已为全球肿瘤医师采纳。
    2.在国际上提出以新孟德尔随机化分析为基础的肿瘤转化流行病学,为此被美国国立癌症研究所,以“特殊才能外国人才引进”为永久研究员。
    3.承担美国国家级课题2项、中国国家自然科学基金2项。发表SCI论文50余篇,累计IF近300分,其中IF 5分以上的有22篇,10分以上10篇,他引近2000次,目前H-index=18。
    学术任职与荣誉
    美国临床肿瘤学会 (ASCO )会员
    美国癌症研究会(AACR)会员
    世界华人肿瘤医师协会华人放射治疗协作组(CRTOG)国际交流工作委员会副主委
    世界华人肿瘤医师协会华人放射治疗协作组(CRTOG)执行委员会委员
    中国国家卫健委特殊医学配方食品评委
    国家自然科学基金委评审专家
    中国抗癌协会肿瘤营养与支持治疗专委会青委会副主任委员
    中国国家卫计委‘十三--五’规划教材《肿瘤学概论》英文版编委
    中国抗癌协会肿瘤营养与支持治疗专业委员会精准肿瘤营养学组副组长
    湖北省中西医结合学会肿瘤专业委员会副主任委员
    湖北省抗癌协会肿瘤放疗专业委员会副主任委员
    湖北省医师协会肿瘤放疗专业委员会副主任委员
    湖北省消化肿瘤专业委员会副主任委员
    湖北省临床肿瘤学会胃癌专业委员会副主任委员
    中国师协会立体定向放疗专业委员会常务委员
    中国医师协会结直肠肿瘤专业委员会委员
    湖北省临床肿瘤学会放射肿瘤学专业委员会秘书长
    湖北省临床肿瘤学会肺癌专业委员会秘书长
    教育履历
    1991.9-1996.6 武汉大学医学院获学士学位
    2001.8-2003.12 香港中文大学医学院临床肿瘤学系获硕士学位
    2005.8-2009.12 香港中文大学医学院公共卫生学院获博士学位
    工作履历
    1996.7-2001.7 湖北荆州一医院肿瘤放化疗科;住院医师,主治医师
    2004.1-2005.8 武汉协和医院肿瘤中心,高年资主治医师(人才引进)
    2009.3-2012.10 美国Vanderbilt University Medical Center肿瘤遗传流行病学博士后
    2012.10-2013.9 美国国立癌症研究所(NCI)放射流行病研究室;联邦研究员(Tenure-track research fellow(VP)永久雇员FTE,特殊才能外国公民人才引进(H1b 签证)
    2013.10-2016.6 副教授,副主任医师,硕士生导师(武汉大学海外人才);武汉大学中南医院肿瘤放化疗科
    2016.7至今 教授,主任医师,博士生导师;武汉大学人民医院肿瘤II科主任
    成果获奖
    1.香港赛马会奖学金(2001.8-2003.12、2005.8-2009.8)
    2.美国癌症研究会(AACR)表现突出会员(2012)
    3.中国抗癌协会全国肿瘤营养先进个人(2018)
    4.武汉大学人民医院优秀导师、优秀教师、先进个人、医疗名家(2018-2022)
    代表性论著
    1. Ge YZ, Fu ZM#, Zhang Q, Song MM, Ruan GT, Zhang X, Zhang XW, Li XR, Zhang KP, Tang M, Liu XY, Yang M, Liu T, Xie HL, Zhang HY, Wang ZW, Hu CL, Lin SQ, Zhang R, Xu HX, Li W, Song CH, Liu M, Chen JQ, Wang KH, Bo L, Cong MH, Li ZN, Guo ZQ, Wang XB, Wang BY, Xu B, Qin XH, Xu XP, Barazzoni R, Yao QH, Weng M, Shen X, Shi HP; IThe Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. AIWW: a new nutrition-screening tool for the oncologic population. Sci China Life Sci (IF=10.372), 2023.DOI: 10.1007/s11427-022-2292-9.PMID: 37121939
    2. Huang K, Xu L, Jia M, Liu W, Wang S, Han J, Li B, Song Q, Fu Z*. Second Primary Malignancies in Cervical Cancer and Endometrial Cancer Survivors: A Population-based Analysis. 2022 May 4;14(9):3836-3855. doi: 10.18632/aging.204047. (IF =5.955)
    3. Han J, Wang B, Liu W, Wang S, Chen R, Chen M, Fu Z*. Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis. Hepatology. 2022 Jan 24. doi: 10.1002/hep.32355. Epub ahead of print. PMID: 35073427. (IF= 17.425)
    4. Fu Z#, Zhang R, Wang KH, Cong MH, Li T, Weng M, Guo ZQ, Li ZN, Li ZP, Wang C, Xu HX, Song CH, Zhuang CL, Zhang Q, Li W, Shi HP; INSCOC Study Group. Development and validation of a Modified Patient-Generated Subjective Global Assessment as a nutritional assessment tool in cancer patients. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):343-354. doi: 10.1002/jcsm.12872. Epub 2021 Dec 4. PMID: 34862759; PMCID: PMC8818590. (IF= 12.91)
    5. Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, Jia M, Song Q, Fu Z*. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol 2020 Apr 11. doi: 10.1007/s00330-020-06854-1. [Epub ahead of print] PMID: 32279115 (IF=5.315,中科院及SCI高引用论文)
    6. Fu Z#, Shrubsole MJ, Li GL, Smalley WE, Hein DW, Chen Z, Yu S, Cai QY, Ness RM, Zheng W. Using gene-environment interaction analyses to clarifying the association of colorectal polyp risk with well-done meat and heterocyclic amine exposure. Am J Clin Nutr, 2012 Nov;96(5):1119-28. PMID: 23015320 (IF= 7.045)
    7. Fu Z#, Shrubsole MJ, Li GL, Smalley WE, Hein DW, Cai QY, Ness RM, Zheng W. Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps. Carcinogenesis, 2013 Apr; 34(4):779-86. (IF= 5.702)
    8. Fu Z#, Shrubsole MJ, Smalley WE, Wu H, Chen Z, Shyr Y, Ness RM, Zheng W. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol, 2012 Nov 1;176(9):766-76. PMID: 23079606 (IF= 5.230)
    9. Wang S, Fu L, Huang K, Han J, Zhang R, Fu Z* . Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019. J Infect. 2021 Feb;82(2):e16-e18.DOI: 10.1016/j.jinf.2020.09.022 PMID: 32979408.(IF=38.637)
    10. Han J, Gong H, Fu L, Chen P, Wang S, Yuan J, Fu Z*. Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea. J Infect. 2020 Aug 5:S0163-4453(20)30536-3. doi: 10.1016/j.jinf.2020.08.003. PMID: 32768451. (IF=38.673)
    11. Han J, Li Q, Li P, Wang S, Zhang R, Qiao Y, Song Q, Fu Z*. Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study. Front Oncol 2020 Mar 10;10:365. doi: 10.3389/fonc.2020.00365. eCollection 2020. PMID: 32266145. (IF=6.244)
    12. Han JL, Lie Z, Long M, Li P, Fu Z* Gastrectomy plus D1 lymph node dissection followed by adjuvant chemoradiotherapy might work as good as gastrectomy plus D2 lymph node dissection in treating locally advanced gastric adenocarcinoma--- A propensity score matching analysis. J Cancer 2020 May 18;11(15):4421-4430. (IF=4.207)
    13. Yu D, Hu W, Chen L, Fu Z, Song Q, Li X. Effect of radiotherapy interruption due to COVID-19 outbreak. Radiother Oncol. 2021 Feb;155:1-2. doi:10.1016/j.radonc.2020.09.055.(IF =6.280)
    14. Wang S, Jia M, Han J, Zhang R, Huang K, Qiao Y, Chen P, Fu Z*. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database. Cancer Med. 2021 Jan;10(2):540-551. doi: 0.1002/cam4.3620. Epub 2020 Nov 28. PMID: 33249743 (IF=4.452)
    15. Wang S, Jia M, Han J, Zhang R, Huang K, Li P, Li Q, Qiao Y, Song Q, Fu Z* Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database. Cancer Biol Ther. 2020 Sep 1;21(9):832-840. (IF=4.742)
    16. Li Q, Zou J, Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y, Song Q, Fu Z*.Palliative gastrectomy and survival in patients with metastatic gastric cancer: a propensity score matched analysis of a large population-based study. Clinical and Translational Gastroenterology.2019 10(5):1-8. DOI:10.14309/ctg.0000000000000048(IF=4.672)
    17. Zhang Q, Zhang K, Li X, Zhang X, Song M, Liu T, Song C, Barazzoni R, Wang K, Xu H, Fu Z*, Shi HP. A novel model with nutrition-related parameters for predicting overall survival of cancer patients.Support Care Cancer 2021 DOI: 10.1007/s00520-021-06272-z PMID: 33973079 (IF=3.603)
    18. Zhang R, Zou J, Li P, Li Q, Qiao Y, Han J, Huang K, Ruan P, Lin H, Song Q, Fu Z*. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort. Dis Esophagus. 2020 Mar 16;33(3). pii: doz051. doi: 10.1093/dote/doz051. PMID: 31175353 (IF=3.429)
    19. Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y, Xu T, Ruan P, Hu Q, Fan G, Song Q, Fu ZM*.Radiotherapy improves the survival of patients with extensive disease small cell lung cancer: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database. Cancer Manag Res. 2018 Nov 29;10:6525-35. doi: 10.2147/CMAR.S174801(IF=3.702)
    20. Zhang R, Li P, Li Q, Qiao Y, Xu T, Ruan P, Song Q, Fu Z*. Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database. Cancer Med. 2018 Oct;7(10):5015-5026. doi: 10.1002/cam4.1776. PMID: 30239162( IF=3.202)
    Name ZHENMING FU
    Date of birth Aug-72
    Department Oncology Department, Renmin Hospital,Wuhan University.
    Title Director, Professor, Chief Physician, doctoral tutor, NIH research fellow
    Email davidfuzming@whu.edu.cn
    TEL 027-88041911-88638
    Research Direction
    1. Precision Oncology for novel chemoradiotherapy
    2 Translational Cancer Epidemiology
    Personal Profile
    1. He has been engaged in clinical and research of precision radiotherapy for oncology, and passed the United States Medical Licensing exam. He has participated in the development of national and international guidelines for a variety of tumors. And his proposed approach to postoperative radiotherapy for gastric cancer has been adopted by oncologists worldwide.
    2. He proposed the translational epidemiology of tumors based on the new Mendelian randomization analysis in the international arena, for which he was admitted to the National Cancer Institute (NCI) as a "foreign talent of special merit".
    3. He has undertaken 2 national projects in the US and 2 national projects in China. He has published more than 50 SCI papers with a cumulative IF score of 200, including 22 papers with an IF score over 5 and 10 papers with an IF score of 10 or more, with nearly 2000 citations and a current H-index=18.
    Selected Publications
    1. Ge YZ#, Fu ZM#, Zhang Q, Song MM, Ruan GT, Zhang X, Zhang XW, Li XR, Zhang KP, Tang M, Liu XY, Yang M, Liu T, Xie HL, Zhang HY, Wang ZW, Hu CL, Lin SQ, Zhang R, Xu HX, Li W, Song CH, Liu M, Chen JQ, Wang KH, Bo L, Cong MH, Li ZN, Guo ZQ, Wang XB, Wang BY, Xu B, Qin XH, Xu XP, Barazzoni R, Yao QH, Weng M, Shen X, Shi HP; IThe Investigation on Nutrition Status and Clinical Outcome of Common Cancers (INSCOC) Group. AIWW: a new nutrition-screening tool for the oncologic population. Sci China Life Sci (IF=10.372), 2023.DOI: 10.1007/s11427-022-2292-9.PMID: 37121939
    2. Huang K, Xu L, Jia M, Liu W, Wang S, Han J, Li B, Song Q, Fu Z*. Second Primary Malignancies in Cervical Cancer and Endometrial Cancer Survivors: A Population-based Analysis. 2022 May 4;14(9):3836-3855. doi: 10.18632/aging.204047. (IF =5.955)
    3. Han J, Wang B, Liu W, Wang S, Chen R, Chen M, Fu Z*. Declining disease burden of HCC in the United States, 1992-2017: A population-based analysis. Hepatology. 2022 Jan 24. doi: 10.1002/hep.32355. Epub ahead of print. PMID: 35073427. (IF= 17.425)
    4. Fu Z#, Zhang R, Wang KH, Cong MH, Li T, Weng M, Guo ZQ, Li ZN, Li ZP, Wang C, Xu HX, Song CH, Zhuang CL, Zhang Q, Li W, Shi HP; INSCOC Study Group. Development and validation of a Modified Patient-Generated Subjective Global Assessment as a nutritional assessment tool in cancer patients. J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):343-354. doi: 10.1002/jcsm.12872. Epub 2021 Dec 4. PMID: 34862759; PMCID: PMC8818590. (IF= 12.91)
    5. Zhang R, Ouyang H, Fu L, Wang S, Han J, Huang K, Jia M, Song Q, Fu Z*. CT features of SARS-CoV-2 pneumonia according to clinical presentation: a retrospective analysis of 120 consecutive patients from Wuhan city. Eur Radiol 2020 Apr 11. doi: 10.1007/s00330-020-06854-1. [Epub ahead of print] PMID: 32279115 (IF=5.315,中科院及SCI高引用论文)
    6. Fu Z#, Shrubsole MJ, Li GL, Smalley WE, Hein DW, Chen Z, Yu S, Cai QY, Ness RM, Zheng W. Using gene-environment interaction analyses to clarifying the association of colorectal polyp risk with well-done meat and heterocyclic amine exposure. Am J Clin Nutr, 2012 Nov;96(5):1119-28. PMID: 23015320 (IF= 7.045)
    7. Fu Z#, Shrubsole MJ, Li GL, Smalley WE, Hein DW, Cai QY, Ness RM, Zheng W. Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps. Carcinogenesis, 2013 Apr; 34(4):779-86. (IF= 5.702)
    8. Fu Z#, Shrubsole MJ, Smalley WE, Wu H, Chen Z, Shyr Y, Ness RM, Zheng W. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol, 2012 Nov 1;176(9):766-76. PMID: 23079606 (IF= 5.230)
    9. Wang S, Fu L, Huang K, Han J, Zhang R, Fu Z* . Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019. J Infect. 2021 Feb;82(2):e16-e18.DOI: 10.1016/j.jinf.2020.09.022 PMID: 32979408.(IF=38.637)
    10. Han J, Gong H, Fu L, Chen P, Wang S, Yuan J, Fu Z*. Clinical and CT imaging features of SARS-CoV-2 patients presented with diarrhea. J Infect. 2020 Aug 5:S0163-4453(20)30536-3. doi: 10.1016/j.jinf.2020.08.003. PMID: 32768451. (IF=38.673)
    11. Han J, Li Q, Li P, Wang S, Zhang R, Qiao Y, Song Q, Fu Z*. Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study. Front Oncol 2020 Mar 10;10:365. doi: 10.3389/fonc.2020.00365. eCollection 2020. PMID: 32266145. (IF=6.244)
    12. Han JL, Lie Z, Long M, Li P, Fu Z* Gastrectomy plus D1 lymph node dissection followed by adjuvant chemoradiotherapy might work as good as gastrectomy plus D2 lymph node dissection in treating locally advanced gastric adenocarcinoma--- A propensity score matching analysis. J Cancer 2020 May 18;11(15):4421-4430. (IF=4.207)
    13. Yu D, Hu W, Chen L, Fu Z, Song Q, Li X. Effect of radiotherapy interruption due to COVID-19 outbreak. Radiother Oncol. 2021 Feb;155:1-2. doi:10.1016/j.radonc.2020.09.055.(IF =6.280)
    14. Wang S, Jia M, Han J, Zhang R, Huang K, Qiao Y, Chen P, Fu Z*. The stage-specific roles of radiotherapy and chemotherapy in nodular lymphocyte predominant Hodgkin lymphoma patients: a propensity score-matched analysis of the SEER database. Cancer Med. 2021 Jan;10(2):540-551. doi: 0.1002/cam4.3620. Epub 2020 Nov 28. PMID: 33249743 (IF=4.452)
    15. Wang S, Jia M, Han J, Zhang R, Huang K, Li P, Li Q, Qiao Y, Song Q, Fu Z* Radiotherapy for patients with stage IV classical Hodgkin lymphoma: a propensity-matched analysis of the surveillance, epidemiology, and end results database. Cancer Biol Ther. 2020 Sep 1;21(9):832-840. (IF=4.742)
    16. Li Q, Zou J, Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y, Song Q, Fu Z*.Palliative gastrectomy and survival in patients with metastatic gastric cancer: a propensity score matched analysis of a large population-based study. Clinical and Translational Gastroenterology.2019 10(5):1-8. DOI:10.14309/ctg.0000000000000048(IF=4.672)
    17. Zhang Q, Zhang K, Li X, Zhang X, Song M, Liu T, Song C, Barazzoni R, Wang K, Xu H, Fu Z*, Shi HP. A novel model with nutrition-related parameters for predicting overall survival of cancer patients.Support Care Cancer 2021 DOI: 10.1007/s00520-021-06272-z PMID: 33973079 (IF=3.603)
    18. Zhang R, Zou J, Li P, Li Q, Qiao Y, Han J, Huang K, Ruan P, Lin H, Song Q, Fu Z*. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort. Dis Esophagus. 2020 Mar 16;33(3). pii: doz051. doi: 10.1093/dote/doz051. PMID: 31175353 (IF=3.429)
    19. Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y, Xu T, Ruan P, Hu Q, Fan G, Song Q, Fu ZM*.Radiotherapy improves the survival of patients with extensive disease small cell lung cancer: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database. Cancer Manag Res. 2018 Nov 29;10:6525-35. doi: 10.2147/CMAR.S174801(IF=3.702)
    20. Zhang R, Li P, Li Q, Qiao Y, Xu T, Ruan P, Song Q, Fu Z*. Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database. Cancer Med. 2018 Oct;7(10):5015-5026. doi: 10.1002/cam4.1776. PMID: 30239162( IF=3.202)